Showing 781 - 800 results of 2,530 for search '"vaccines"', query time: 0.08s Refine Results
  1. 781

    The Adoption Process to Technology Biosecurity and Vaccination in the Dispersal of Foot and Mouth Disease Bone Regency, South Sulawesi Province by Rismayanti Rismayanti

    Published 2025-01-01
    “… Adopting biosecurity and vaccination technology is one of the steps that can be taken to overcome and minimize FMD disease in beef cattle farming. …”
    Get full text
    Article
  2. 782

    Ecological study of the association between the English national vaccination programme and area deprivation inequalities in COVID-19 mortality by Clare Bambra, Adam Todd, Fiona Matthews, David Sinclair, Natalie Bennett

    Published 2025-01-01
    “…However, more could be achieved if barriers to vaccination uptake in the most deprived areas are overcome.…”
    Get full text
    Article
  3. 783

    The immunogenicity of PRV ΔgE/TK/UL49.5 three-gene-deleted vaccine in mice by Chenmeng Ding, Yawei Sun, Xianfeng Zhang, Mengmeng Shi, Han Yang, Xin Zhou, Shuangshuang Li, Yongtao Li, Xia Yang, Linyang Yu, Lu Chen

    Published 2025-02-01
    “…Abstract Background Pseudorabies (PR) caused by the re-emerging of pseudorabies virus (PRV) variant has outbroken among PRV vaccine immunized swine in many pig farms, which has caused serious social and economic consequences since the end of 2011. …”
    Get full text
    Article
  4. 784
  5. 785

    A Case Report of DVT following the Johnson and Johnson Vaccine against the Novel SARS-CoV-2 by Ayrton Bangolo, Jeffin Cherian, Mohamed Ahmed, Ali Atoot, Bhavna Gupta, Adam Atoot

    Published 2022-01-01
    “…In this case report, we present a female who developed a DVT four days after receiving the J&J vaccine. We propose that the administration of this vaccine may further increase the risk of developing DVTs in patients with previous risk factors, and we hope to use this case to support screening all patients for previous risk factors for thrombosis before administration of the J&J vaccine.…”
    Get full text
    Article
  6. 786
  7. 787
  8. 788
  9. 789
  10. 790

    Acute Myopericarditis after the Second Dose of mRNA COVID-19 Vaccine Mimicking Acute Coronary Syndrome by Chris Pantsios, Zacharias-Alexandros Anyfantakis, Andrew Xanthopoulos, Ioannis Leventis, Spyridon Skoularigkis, Apostolos Dimos, Angeliki Bourazana, Michail Papamichalis, Grigorios Giamouzis, Filippos Triposkiadis, John Skoularigis

    Published 2022-01-01
    “…Myocarditis is a rare adverse event of vaccination. Recently, mRNA vaccines for COVID-19 have been reported to correlate with myocarditis, specifically in adolescents and young men. …”
    Get full text
    Article
  11. 791
  12. 792

    Vaccination with Enzymatically Cleaved GPI-Anchored Proteins from Schistosoma mansoni Induces Protection against Challenge Infection by Vicente P. Martins, Carina S. Pinheiro, Barbara C. P. Figueiredo, Natan R. G. Assis, Suellen B. Morais, Marcelo V. Caliari, Vasco Azevedo, William Castro-Borges, R. Alan Wilson, Sergio C. Oliveira

    Published 2012-01-01
    “…Current schistosomiasis control strategies are mainly based on chemotherapy, but many researchers believe that the best long-term strategy to control schistosomiasis is through immunization with an antischistosomiasis vaccine combined with drug treatment. In the search for potential vaccine candidates, numerous tegument antigens have been assessed. …”
    Get full text
    Article
  13. 793
  14. 794
  15. 795
  16. 796
  17. 797
  18. 798

    Resistance of Fry from Vaccinated Mother of Gift Tilapia (Oreochromis niloticus Linn.) to Artificial Infection of Streptococcus iniae by I. Nur, . Sukenda, D. Dana

    Published 2007-04-01
    “… An investigation was made to study the efficacy of dosage and time of administration in maternal vaccination. Mothers of nile tilapia were vaccinated by intraperitoneal injection with adjuvant-heat killed Streptococcus iniae at one and two weeks after spawning at the dosages of 0,2 ml/kg and 0,4 ml/kg body weight. …”
    Get full text
    Article
  19. 799
  20. 800